Discontinuation of Eculizumab Maintenance Treatment for Atypical Hemolytic Uremic Syndrome: A Report of 10 Cases
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference32 articles.
1. Complement regulatory genes and hemolytic uremic syndromes;Kavanagh;Annu Rev Med,2008
2. Complement inhibitor eculizumab in atypical hemolytic uremic syndrome;Mache;Clin J Am Soc Nephrol,2009
3. Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report;Châtelet;Transplant Proc,2010
4. Clinical practice. Today's understanding of the haemolytic uraemic syndrome;Scheiring;Eur J Pediatr,2010
5. Non-enteropathic hemolytic uremic syndrome: causes and short-term course;Constantinescu;Am J Kidney Dis,2004
Cited by 171 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ex vivo C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy;Kidney International Reports;2024-07
2. Recurrent complement-mediated Hemolytic uremic syndrome after kidney transplantation;Transplantation Reviews;2024-07
3. Eculizumab as first line treatment for patients with severe presentation of Complement Factor H antibodies mediated Hemolytic Uremic Syndrome;2024-06-13
4. Complement‐driven hemolytic uremic syndrome;American Journal of Hematology;2023-03-31
5. Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation;Blood Advances;2023-01-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3